ARC1905
Showing 1 - 11 of 11
Geographic Atrophy, Macular Degeneration Trial in Dallas (Avacincaptad pegol 2 mg intravitreal injection)
Not yet recruiting
- Geographic Atrophy
- Macular Degeneration
- Avacincaptad pegol 2 mg intravitreal injection
-
Dallas, TexasRetina Foundation of the Southwest
Sep 7, 2022
Geographic Atrophy, Macular Degeneration Trial in Worldwide (Zimura, Sham)
Completed
- Geographic Atrophy
- Macular Degeneration
- Zimura
- Sham
-
Phoenix, Arizona
- +77 more
Mar 17, 2022
Wet Age-related Macular Degeneration Trial in Hungary, Latvia, United States (Zimura, Lucentis)
Completed
- Wet Age-related Macular Degeneration
-
Phoenix, Arizona
- +27 more
Feb 3, 2022
Age-Related Macular Degeneration Trial in New York (ARC1905)
Completed
- Age-Related Macular Degeneration
- ARC1905
-
New York, New YorkOphthotech
Aug 23, 2017
Coronary Artery Disease, In Stent Restenosis Trial in China (drug-coated balloon Catheter)
Unknown status
- Coronary Artery Disease
- In Stent Restenosis
- drug-coated balloon Catheter
-
Hefei, An Hui, China
- +18 more
Feb 17, 2020
Chronic Coronary Occlusion, Unprotected Left Main Coronary Artery Disease, Stent Thrombosis Trial in Santa Clara (Percutaneous
Completed
- Chronic Coronary Occlusion
- +8 more
- Percutaneous Coronary Intervention
- CABG
-
Santa Clara, CaliforniaAbbott Vascular
Mar 24, 2020
BVS-OCT Imaging Study
Completed
- Coronary Disease
- BVS implantation
-
New York, New YorkIcahn School of Medicine at Mount Sinai
May 4, 2018
Age-Related Macular Degeneration Trial in New York (ARC1905)
Completed
- Age-Related Macular Degeneration
- ARC1905
-
New York, New YorkOphthotech Corp
Jun 14, 2012